Joint pain supplement reduces premature death risk as effectively as exercise, study suggests


Watch: Glucosamine-chondroitin supplement may ward off early death

A daily glucosamine-chondroitin supplement may be as effective as exercise when it comes to warding off an early death, research suggests.

Working up a sweat has known benefits, with regular physical activity up to halving the risk of heart disease, type 2 diabetes and cancer, to name a few conditions.

Glucosamine and chondroitin are naturally-occurring substances found in cartilage. The two compounds are often combined in over-the-counter supplements that are marketed to ease joint pain or osteoarthritis.

After examining the supplement intake of more than 16,000 adults, scientists from West Virginia University found those who took a glucosamine-chondroitin supplement every day for at least 12 months were 39% less likely to die from any cause over the next eight years.

Read more:Exceed exercise recommendations to offset prolonged sitting

Results further suggested the daily pill cut the risk of heart disease deaths

Read More

Study: Air pollution exposure may be linked to Alzheimer’s disease risk


Older adults exposed to air pollution might have a heightened risk of abnormal “plaque” accumulation in the brain, a new study suggests.

Plaques refer to clumps of protein called beta-amyloid that build up in the brains of people with Alzheimer’s disease.

In the new study, researchers found that among older adults with memory and thinking problems, those exposed to higher levels of air pollution were more likely to show plaque buildup on brain scans.

The findings do not prove air pollution causes plaques or dementia, said lead researcher Leonardo Iaccarino, a postdoctoral fellow at the University of California, San Francisco’s Memory and Aging Center.

But the results add to a body of research suggesting that air pollution is a risk factor for dementia.

A recent study, for example, found that older Americans living in polluted ZIP codes had higher odds of being hospitalized for dementia or Parkinson’s disease than people

Read More

Germany Aims to Have First Risk Groups Vaccinated in January | World News


BERLIN (Reuters) – Germany aims to have the first vulnerable people and caregivers vaccinated against the coronavirus in January, the health minister said on Tuesday, as the European Union’s (EU) most populous country battles a second wave.

“But it remains true, and we have always said, that the cold winter months, in which we spend more time indoors, will be the harder part. That actually applies until the end of winter,” Jens Spahn told public broadcaster Deutschlandfunk.

German authorities are preparing special vaccination centres due to be ready in mid-December even though a vaccine will probably not be available by that time, Spahn added.

Health workers will vaccinate people with mobile teams and at vaccination centres since a candidate developed by Biontech and Pfizer needs to be stored at -70 degrees Celsius, Spahn said.

He added that he expects more vaccines, which can be administered by general practitioners, in spring

Read More

Type O blood linked to lower COVID risk, taking Vitamin D unlikely to help


(Reuters) – The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

FILE PHOTO: The ultrastructural morphology exhibited by the 2019 Novel Coronavirus (2019-nCoV), which was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China, is seen in an illustration released by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, U.S. January 29, 2020. Alissa Eckert, MS; Dan Higgins, MAM/CDC/Handout via REUTERS

Certain blood groups less likely to get COVID-19

A large study adds to evidence that people with type O or Rh−negative blood may be at slightly lower risk from the new coronavirus. Among 225,556 Canadians who were tested for the virus, the risk for a COVID-19 diagnosis was 12% lower and the risk for severe COVID-19 or death

Read More

Type O Blood Linked to Lower COVID Risk, Taking Vitamin D Unlikely to Help | Top News


(Reuters) – The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

Certain blood groups less likely to get COVID-19

A large study adds to evidence that people with type O or Rh−negative blood may be at slightly lower risk from the new coronavirus. Among 225,556 Canadians who were tested for the virus, the risk for a COVID-19 diagnosis was 12% lower and the risk for severe COVID-19 or death was 13% lower in people with blood group O versus those with A, AB, or B, researchers reported on Tuesday in Annals of Internal Medicine. People in any blood group who were Rh-negative were also somewhat protected, especially if they had O-negative blood. People in these blood type groups may have developed antibodies that can recognize some aspect of

Read More

Three Key Factors Tied to Higher Suicide Risk in BPD


Three specific symptoms may help clinicians identify patients with borderline personality disorders (BPD) at highest risk for suicide.

Results of a large longitudinal study show patients with BPD are at considerably higher risk of suicide attempts compared to patients with other personality disorders including schizotypal, avoidant, and obsessive compulsive personality disorder (OCPD).

Furthermore, among DSM-5 diagnostic criteria for BPD, the study identified three as the most significant independent risk factors for suicide attempts in this patient population. They included identity disturbance, chronic feelings of emptiness, and frantic efforts to avoid abandonment.

The take-home message for clinicians is they should screen for these three factors in patients with BPD when assessing suicide risk, study investigator Shirley Yen, PhD, associate professor, Harvard Medical School, Boston, Massachusetts, told Medscape Medical News.

The study was published online November 18 in JAMA Psychiatry.

Unique Features

Individuals with psychiatric disorders are at increased risk

Read More

MS has mixed impact on risk for cancer, study says


How does having multiple sclerosis affect a person’s odds for cancer? The answer may depend on the type of cancer, new research shows.

The study found that MS patients do have much greater odds of developing bladder cancer compared to people without the illness. But there was good news, too: Their risk of breast and colon cancer is no higher than for people who don’t have MS, according to the Canadian researchers.

Why MS patients are prone to bladder cancer isn’t clear.

“We can only speculate about the reason for this finding,” said lead researcher Dr. Ruth Ann Marrie, a professor of medicine and community health sciences at the University of Manitoba in Winnipeg.

She pointed out that people with MS have an increased rate of urinary tract infections and are more likely to use indwelling, or Foley, catheters, which remain in the bladder, than people without MS.

“These factors

Read More

Wiping down groceries? Experts say keep risk in perspective


NEW YORK (AP) — Cleaning wipes are harder to find on store shelves, and businesses are reassuring customers with stepped up sanitation measures. In New York, the subway system is shut down nightly for disinfecting.

To avoid any traces of the coronavirus that might be lurking on surfaces, Americans have been wiping down groceries, wearing surgical gloves when they go out and leaving mail packages out for an extra day or two. But experts say the national fixation on scrubbing sparked by the pandemic can sometimes be overkill.

“It’s important to clean surfaces, but not to obsess about it too much in a way that can be unhealthy,” said Dr. John Brooks, chief medical officer for the COVID-19 response at the U.S. Centers for Disease and Control.

Health officials knew less about the virus in the early days of the pandemic, but say it’s become clearer the main way it

Read More

Study: Heart failure risk in older women increases with more sedentary time


Nov. 24 (UPI) — Older women have a greater risk of heart failure if they spend more time sitting than those who sit less — even if they have a regular fitness routine — a new study found.

Researchers analyzed records for nearly 80,100 postmenopausal women, who were 63 years of age on average, from the Women’s Health Initiative Observational Study, for the study published Tuesday.

The initiative allowed women to self-report time spent sitting or lying down in waking hours and or moving.

Women who spent less than 6.5 hours a day sitting or lying down in waking hours, had 15% less risk of heart failure hospitalization than women reporting up to 9.5 sedentary hours, and 42% less risk than women reporting more than 9.5 hours sedentary hours, the data showed.

Analysts gathered data from an average of nine years of follow-up on the women, during which 1,402 women

Read More

This Surprising Supplement Can Cut Your COVID Risk, New Study Says


Coronavirus has been particularly devastating in recent weeks, but thankfully, there are also glimmers of hope. Beyond Pfizer’s early vaccine data and promising developments in potential treatments, we’ve also gained new insights on ways we can take our safety into our own hands. One such insight, published recently in the journal PLOS Biology, has identified a popular supplement that may just cut your COVID risk significantly: the popular sleep aid, melatonin.

Using an artificial intelligence platform designed to identify possible drugs that could be repurposed to fight COVID-19, the researchers sifted through data from the Cleveland Clinic’s COVID-19 registry. They found that those patients that routinely took melatonin were 30 percent less likely to test positive for SARS-CoV-2, the virus that causes COVID-19. Notably, the risk reduction was even more stark among African Americans: their chances of contracting coronavirus were lowered by 52 percent compared with the general patient

Read More